Sublingual immunotherapy and allergic rhinitis.

Current Allergy and Asthma Reports
Linda S Cox

Abstract

This paper reviews the safety and efficacy of sublingual immunotherapy (SLIT) in the treatment of allergic rhinitis. The literature from 1986 through 2007 shows approximately a 6000-fold range in doses found to be effective with SLIT. However, recent studies in large patient populations have demonstrated a clear dose response with an effective dose range that appears to be equivalent to one to two times the monthly subcutaneous immunotherapy dose administered daily or weekly (ie, 15 to 30 microg of major allergen). Further study is needed to establish the optimal dose and dosing schedule for each formulation. Local reactions (eg, oral itchiness) are common, and serious adverse reactions, although rare, have been reported. Cost-effective analysis cannot be made until the effective dose is established. SLIT appears to be a promising treatment for allergic rhinitis, but it is currently considered investigational in the United States until a formulation approved by the US Food and Drug Administration is available.

Associated Clinical Trials

References

Oct 1, 1992·The Journal of Allergy and Clinical Immunology·G E Stewart, R F Lockey
Apr 1, 1987·The Journal of Allergy and Clinical Immunology·R F LockeyS C Bukantz
Feb 1, 1982·The Journal of Allergy and Clinical Immunology·T E Van MetreG L Rosenberg
Jul 1, 1993·The Journal of Allergy and Clinical Immunology·M J ReidT A Platts-Mills
Aug 1, 1993·The Journal of Allergy and Clinical Immunology·H S NelsonA Buchmeier
Aug 12, 1999·The New England Journal of Medicine·S R DurhamK T Nouri-Aria
Oct 12, 2000·The New England Journal of Medicine·UNKNOWN Childhood Asthma Management Program Research GroupRobert Zeiger
Sep 1, 2001·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·F Purello-D'AmbrosioL Ricciardi
Feb 13, 2003·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·V Di RienzoG Passalacqua
Jun 14, 2003·The Cochrane Database of Systematic Reviews·D R WilsonS R Durham
Jun 23, 2004·The Journal of Allergy and Clinical Immunology·David I BernsteinUNKNOWN Immunotherapy Committee, American Academy of Allergy, Asthma and Immunology
Oct 14, 2004·The Journal of Allergy and Clinical Immunology·Elio NovembreAlberto Vierucci
Jan 3, 2006·The Journal of Allergy and Clinical Immunology·Hetal S AminDavid I Bernstein
Feb 8, 2006·The Journal of Allergy and Clinical Immunology·Anthony J FrewUNKNOWN UK Immunotherapy Study Group
May 6, 2006·The Journal of Allergy and Clinical Immunology·Linda S CoxHarold S Nelson
May 12, 2006·The New England Journal of Medicine·Theresa W GuilbertFernando D Martinez
Aug 8, 2006·The Journal of Allergy and Clinical Immunology·Ronald DahlStephen R Durham
Aug 30, 2006·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Vasco Bordignon, Samuele E Burastero
Sep 1, 2006·Allergy·E H DunskyG A Belecanech
Sep 1, 2006·Allergy·A AnticoA Crema
Jan 27, 2007·The Cochrane Database of Systematic Reviews·M A CalderonS Durham
Mar 24, 2007·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Maurizio MarognaGiovanni Passalacqua
Apr 26, 2007·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·C BachertP B Poulsen
May 25, 2007·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Linda Cox, John R Cohn
Oct 6, 2007·The Journal of Allergy and Clinical Immunology·UNKNOWN Joint Task Force on Practice ParametersUNKNOWN Joint Council of Allergy, Asthma and Immunology
Nov 13, 2007·The Journal of Allergy and Clinical Immunology·Linda CoxUNKNOWN American College of Allergy, Asthma and Immunology
Dec 25, 2007·The Journal of Allergy and Clinical Immunology·Ronald DahlStephen R Durham
Dec 15, 2010·The Cochrane Database of Systematic Reviews·Suzana RadulovicStephen Durham

❮ Previous
Next ❯

Citations

Feb 13, 2009·Current Allergy and Asthma Reports·Simi Kapoor, Leonard Bielory
Apr 28, 2009·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·John H Krouse
Mar 7, 2012·American Journal of Rhinology & Allergy·Sarah K Wise, Rodney J Schlosser
Sep 18, 2012·Otolaryngologic Clinics of North America·Sarah K Wise, Rodney J Schlosser
Dec 3, 2008·The Journal of Allergy and Clinical Immunology·Ulrich WahnUNKNOWN SLIT Study Group
Jun 21, 2012·International Forum of Allergy & Rhinology·Kristin SeiberlingDennis Chang
Mar 2, 2016·Current Opinion in Otolaryngology & Head and Neck Surgery·William R Reisacher, Theresa Schwanke
Nov 3, 2009·Therapeutic Advances in Respiratory Disease·Cevdet Ozdemir
Nov 4, 2008·Current Opinion in Allergy and Clinical Immunology
Mar 25, 2009·Current Opinion in Allergy and Clinical Immunology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
Ivor A EmanuelOren Traub
The Journal of Allergy and Clinical Immunology
Linda S CoxHarold S Nelson
© 2022 Meta ULC. All rights reserved